GT201200079A - Composición farmacéutica para bajar de peso y procedimiento para obtener la misma - Google Patents

Composición farmacéutica para bajar de peso y procedimiento para obtener la misma

Info

Publication number
GT201200079A
GT201200079A GT201200079A GT201200079A GT201200079A GT 201200079 A GT201200079 A GT 201200079A GT 201200079 A GT201200079 A GT 201200079A GT 201200079 A GT201200079 A GT 201200079A GT 201200079 A GT201200079 A GT 201200079A
Authority
GT
Guatemala
Prior art keywords
pharmaceutical composition
procedure
lower weight
same
pharmaceutical
Prior art date
Application number
GT201200079A
Other languages
English (en)
Inventor
García Armenta María Elena
Santos Murillo Josefina
Álvarez Ochoa Víctor Guillermo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT201200079A publication Critical patent/GT201200079A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA PRESENTE INVENCIÓN ESTÁ RELACIONADA CON LAS TÉCNICAS UTILIZADAS EN LA INDRUSTRIA FARMACÉUTICA Y MÁS PARTICULARMENTE, ESTÁ RELACIONADA CON UNA COMPOSICIÓN FARMACÉUTICA PARA BAJAR DE PESO QUE COMPRENDE COMO INGREDIENTES ACTIVOS ORLISTAT Y L-CARNITINA, ASÍ COMO EL PROCEDIMIENTO PARA OBTENER LA MISMA.
GT201200079A 2009-09-18 2012-03-16 Composición farmacéutica para bajar de peso y procedimiento para obtener la misma GT201200079A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2009009971A MX342962B (es) 2009-09-18 2009-09-18 Composicion farmaceutica para bajar de peso y procedimiento para obtener la misma.

Publications (1)

Publication Number Publication Date
GT201200079A true GT201200079A (es) 2014-01-27

Family

ID=43758159

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201200079A GT201200079A (es) 2009-09-18 2012-03-16 Composición farmacéutica para bajar de peso y procedimiento para obtener la misma

Country Status (8)

Country Link
EP (1) EP2478902A4 (es)
AR (1) AR078185A1 (es)
BR (1) BR112012006013A2 (es)
CO (1) CO6541522A2 (es)
EC (1) ECSP12011800A (es)
GT (1) GT201200079A (es)
MX (1) MX342962B (es)
WO (1) WO2011033356A1 (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
IT1305308B1 (it) * 1999-03-26 2001-05-04 Biosint S P A Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione
WO2003009840A1 (en) * 2001-07-24 2003-02-06 Lonza Ag Composition comprising at least one lipase inhibitor and carnitine
CN1546017A (zh) * 2003-11-30 2004-11-17 杨喜鸿 奥利司他的复方制剂
JP2006191830A (ja) * 2005-01-12 2006-07-27 Unitika Ltd 脂肪の蓄積を抑制する食品
TR200607613A2 (tr) * 2006-12-29 2008-07-21 NOBEL İLAÇ SAN.ve TiC.A.Ş. Lipaz inhibitörü içeren farmasötik formülasyonlar
EP2002825B1 (en) * 2007-06-14 2013-05-22 Krka Pharmaceutical compositions comprising orlistat
CN101224202A (zh) * 2007-12-26 2008-07-23 广州康采恩医药有限公司 减肥组合物

Also Published As

Publication number Publication date
EP2478902A1 (en) 2012-07-25
WO2011033356A1 (es) 2011-03-24
MX342962B (es) 2016-06-07
AR078185A1 (es) 2011-10-19
ECSP12011800A (es) 2012-05-30
BR112012006013A2 (pt) 2016-06-14
EP2478902A4 (en) 2014-05-14
MX2009009971A (es) 2011-03-18
CO6541522A2 (es) 2012-10-16

Similar Documents

Publication Publication Date Title
CR20110609A (es) Composicion antimicrobiana y metodos relacionados de uso
CL2016000873A1 (es) Analogos de glucagon acilado, una composicion que lo comprende; su uso para la fabricacion de un medicamento util para impedir el aumento de peso; un kit y un procedimiento.
CL2015001984A1 (es) (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos.
GT201400136A (es) Compuestos y métodos de benzaldehído substituído para su uso en incrementar la oxigenación de los tejidos
GT201400043A (es) Imidazopiridazinas sustituidas con amino
GT201200276A (es) Combinaciones de compuestos activos
GT201400147A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
UY35040A (es) Pirrolopirimidinilamino-benzotiazolonas sustituidas
GT201400111A (es) Triazolopiridinas sustituidas
PA8660301A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
UY32728A (es) Composición farmacéutica y procedimiento de tratamiento para la anticoncepción de emergencia
ECSP11011487A (es) Pirazinilpirazoles
BR112012020839A2 (pt) vacinas para uso na profilaxe e tratamento de doença de vírus da influenza
CR20110100A (es) Nuevos derivados de sulfamida sustituida
DOP2016000253A (es) Nuevos compuestos
CL2019001940A1 (es) Composiciones antimicrobianas y métodos de uso relacionados (divisional de solicitud 2519-2015).
UY31788A (es) Formulación farmacéutica sólida con liberación retardada
DOP2016000118A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
CR20150455A (es) Imidazopiridazinas sustituidas
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
DOP2016000007A (es) Pirazolpiridinas sustituidas
CR20110190A (es) Agente rodenticida sinérgico
BR112012007798A2 (pt) microcápsulas estáveis e composição para aplicação tópica e método para a preparação de microcápsulas
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR082215A1 (es) Composicion farmaceutica agradable al paladar